Trial Profile
The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Ginkgo biloba
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms GINGER
- 15 Oct 2011 Results presented at the 13th European AIDS Conference.
- 11 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.